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TECHNICAL NOTE
Quantifying porphobilinogen deaminase mRNA in
microdissected nephron segments by a modified RT-PCR
DONG SUN, GEORGE SEKI, SHU UWATOKO, AKIHIDE NAKAO, ATSUO GOTO, TOSHIRO FUJITA,
SATOSHI KIMURA, and SHIGEO TANIGUCHI
Departments of Nephrology and Endocrinology, Infectious Diseases, Faculty of Medicine, University of Tokyo, Tokyo, Japan
Quantifying porphobilinogen deaminase mRNA in microdis- The housekeeping type of PBGD mRNA is believed
sected nephron segments by a modified RT-PCR. to present with uniform tissue expression [1, 2]. How-
Background. Quantifying mRNA levels by reverse transcrip- ever, we found that tubular PBGD mRNA expressiontion-polymerase chain reaction (RT-PCR), although widely ex-
was much more abundant than those in glomeruli.ercised, is still difficult.
Methods. A modified quantitative RT-PCR in which geno-
mic DNA was used as standard was developed. The quantity
METHODSof mRNA was expressed as the ratio of the PCR product
from cDNA and that from genomic DNA (CG ratio). Nephron Chemicals and reagents
distribution of porphobilinogen deaminase (PBGD) mRNA
DNA oligonucleotides used as primers were synthe-was examined in microdissected nephron segments using the
sized from Funakoshi (Tokyo, Japan) in a determinedmethod. The enzyme activity and mRNA quantity of PBGD
also were measured in tissue homogenates. order. Avian myeloblastosis virus (AMV) reverse tran-
Results. Tubular segments expressed substantially more scriptase and RNase inhibitors were purchased from
PBGD mRNA than glomeruli (expressed as CG ratios, 1.04  Roche Diagnostics (Mannheim, Germany), uracil DNA0.10 in glomeruli, 4.53 0.32 in PCT, 5.71 0.25 in PST, 5.13
glycosylase (UDG) from Life Technologies (Rockville,0.52 in mTAL, 5.29  0.20 in cTAL, 4.05  0.35 in DCT,
MD, USA), and TAQ polymerase from Takara (Kyoto,2.88 0.25 in CCD, and 4.90 0.24 in OMCD). PBGD mRNA
level in liver homogenate (3.17  0.36) was much higher than Japan). Porphobilinogen (PBG) was obtained from Por-
glomeruli but lower than most of the tubular segments. The phyrin Products (Logan, UT, USA).
enzyme activity in tissue homogenates correlated well with
mRNA levels. Preparation of mRNA and DNAConclusion. The method reported here is simple and reli-
able, and especially suitable for quantitating specific mRNA Six- to eight-week-old male Sprague-Dawley rats were
amounts in minute tissue samples such as microdissected neph- used. Nephron segments were obtained by microdissec-
ron segments. tion as previously reported [3]. In brief, the left kidney was
perfused with “incubation solution” [Dulbecco’s modified
Eagle’s medium (DMEM) solution containing 0.1% colla-
With the explosive advances in biological sciences, genase and 0.1% bovine serum albumin (BSA)] and sliced
studies on specific gene expressions at cell level have with a razor blade. Tissue fragments were then incubated
become increasingly more important. The present study in the incubation solution for 30 minutes at 37C. Micro-
introduces a simple and reliable method for quantifying dissection was performed at 4C in “microdissection so-
mRNA levels in minute tissue samples by a modified re- lution” containing (in mmol/L) 137 NaCl, 4 KCl, 1 CaCl2,verse transcription-polymerase chain reaction (RT-PCR). 1 KH2PO4, 1 MgSO4, 5 glucose, 5 lactate, 10 N-2-ethane-Using this method, we examined porphobilinogen de- sulfonic acid, and 0.1% BSA; and the pH was adjusted
aminase (PBGD) mRNA expression in microdissected to 7.4 with NaOH. Microdissected nephron segments
nephron segments. (10 glomeruli or 2 mm of each tubular segment) were
rinsed carefully in another dish and transferred to a 1.5
mL tube. Then, 90 L of “denaturing solution” (4 mol/LKey words: gene expression, tissue sample, quantifying mRNA, kid-
ney, micro measurement technique. guanidinium thiocyanate, 25 mmol/L sodium citrate, pH
7.0, 0.5% sarcosyl, and 0.1 mol/L 2-mercaptoethanol)Received for publication January 4, 2001
was added and the tubes were vortexed to lyse the cells.and in revised form August 7, 2001
Accepted for publication August 15, 2001 In the tubes 10 g of tRNA (as the carrier), 10 L of 3
mol/L sodium acetate (pH 5.3), and 300 L of ethanol 2002 by the International Society of Nephrology
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Table 1. Primers used in mutagenic reverse transcription-polymerase chain reaction (MRT-PCR)
of porphobilinogen deaminase (PBGD) and -actin
Primer Sequence Base number
PBGD [References 4, 6]
RT 5-UCAUUAAGCUGCCGUGCAACAUCUAGGAUGCCCAGGUUCGCAGCA-3 1056-1081,
995-1013 (exon 14)
Sense SAC 5-CAUCCAGGUCCCUGUUCAGCAAGA-3 898-922 (exon 13, 14)
Sense PCR 5-CATAGGATGACCCACAGTTG-3 931-950 (exon 14)
Antisense PCR 5-TCATTAAGCTGCCGTGCAAC-3 1062-1081 (exon 14)
Expected product length: genomic DNA, 151 bp; cDNA, 109 bp
-actin [Reference 26]
RT 5-GAGCGCGUAACCCUCAUAGAUGGGCACAGUGGUACGACCAGA-3 2227-2242,
2282-2307 (exon 4)
Sense SAC 5-CCGUGAAAAGAUGACCCAGAUCAU-3 1675-1693 (exon 3),
2158-2162 (exon 4)
Sense SAG 5-AGCTTGACAATACTGTATTCC-3 2126-2146 (intron 3)
Antisense SAG 5-CAGACGCAGGATGGCATGA-3 2310-2329 (exon 4)
Sense PCR 5-GTTTGAGACCTTCAACACCC-3 2163-2182 (exon 4)
Antisense PCR 5-GAGCGCGTAACCCTCATAG-3 2288-2307 (exon 4)
Expected product length: genomic DNA, 145 bp; cDNA, 106 bp
were added and stored at20C overnight to precipitate maining RT primer may anneal with genomic DNA and
consequently cause a false-positive result. In the presentthe nucleic acids. The tubes were then centrifuged, and
the pellets were rinsed with 70% ethanol and used in study this problem was resolved using a system of UDG
[5]. RT primers were sensitized to UDG by replacing allsubsequent steps. In this way, both RNA and DNA in
the sample were totally recovered. of the T residues with U residues. Prior to PCR, the
samples were incubated with UDG to eliminate all of
MRT-PCR of PBGD the remaining RT primers. This step also will truncate
the 3 end of the first-strand cDNA (the part of cDNAThe present study involved use of a modified quantita-
tive RT-PCR based on mutagenic RT-PCR (MRT-PCR) derived from the RT primer itself). Prior to UDG treat-
ment, the second-strand cDNA that was resistant to theas reported [3]. The principle of the original MRT-PCR
was as follows: introduction of a point mutation in cDNA enzyme treatment was synthesized by one cycle of PCR.
The primer used in this step was designed to anneal onlyduring the RT step, parallel amplification by PCR of
cDNA and corresponding sequence of genomic DNA with cDNA. The structure of the rat PBGD gene was
deduced from the reported sequence of the mouse PBGDusing a set of primers on the same exon, and estimation
of the amount of mRNA per cell by comparing the PCR gene [6], and the primer was designed to span exons 13
and 14. Thus, the procedure resulted in selective ampli-product from cDNA and that from genomic DNA. The
present study describes several improvements in the fication of cDNA (SAC). Primer used for SAC (SAC
primer; Table 1) was added to the samples and one cyclemethod, as will be discussed here in detail:
The primers used in the present study are listed in of PCR (denaturing at 94C for 40 sec, annealing at 60C
for 40 sec, and extension at 72C for 20 sec) was per-Table 1. Pellets of nucleic acids were dissolved in RT
buffer containing RNase inhibitor and a specific RT formed. Then UDG, PCR primers, and TAQ polymerase
were added; after UDG treatment (incubation at 35Cprimer. Samples were heated once to 60C and cooled
to 42C to denature possible secondary structures of for 30 min), 40 cycles of PCR was performed.
Both PCR primers were designed on exon 14 so thatmRNA and to promote complete annealing of the RT
primer to mRNA. AMV reverse transcriptase was then the corresponding sequence of genomic DNA was ampli-
fied during PCR in parallel with cDNA. Sense PCRadded and reverse transcription was performed at 42C
for 60 minutes. The RT primer was designed to introduce primer was downstream on the SAC primer (Table 1)
and served as a “nested primer” to intensify the specific-a deletion mutation in the cDNA. The primer was a
DNA oligonucleotide of 45 bases and with a sequence ity of the product [7]. Antisense PCR primer was identi-
cal to the 3 part of RT primer except that T residuescorresponding to two separate parts of the rat PBGD
gene: bases 995 to 1013 and 1056 to 1081 of the reported were used instead of U residues. PCR cycles were dena-
turing at 94C for 40 seconds, annealing at 60C for 40sequence of rat PBGD cDNA [4]. The portion corre-
sponding to bases 1014 to 1055 was omitted. Thus, the seconds, and extension at 72C for 20 seconds. After 40
cycles of PCR, the samples were analyzed on acrylamidesynthesized cDNA has 42 deleted bases compared to the
corresponding sequence of genomic DNA. gel electrophoresis. Images of PCR products stained with
ethydium bromide were analyzed using NIH image soft-The MRT-PCR system is problematic in that the re-
Sun et al: Quantifying PBGD mRNA by RT-PCR338
Table 2. PBGD mRNA levels in nephron segments
Segment PBGD mRNA
Glomeruli 1.040.10
PCT 4.530.32
PST 5.710.25
mTAL 5.130.52
cTAL 5.290.20Fig. 1. Results of mutagenic reverse transcription-polymerase chain
DCT 4.050.35reaction (MRT-PCR) of porphobilinogen deaminase (PBGD) mRNA.
CCD 2.880.25The results of MRT-PCR of PBGD in four different nephron segments,
OMCD 4.900.24glomeruli (GL), proximal convoluted tubule (PCT), cortical thick as-
cending limb of Henle (cTAL), and distal convoluted tubule (DCT) Data are: CG ratio, mean  SE, N  5. Abbreviations are: PCT, proximal
convoluted tubule; PST, proximal straight tubule; mTAL, medullary thick as-are shown. For each segment, RT () control is shown in the lane next
cending limb of Henle; cTAL, cortical thick ascending limb of Henle; DCT,to that of RT () sample. For each lane, the upper bands represent
distal convoluted tubule; CCD, cortical collecting duct; OMCD, outer medullarythe products of genomic DNA and the lower bands that are lacking in
collecting duct.RT () controls represent those of cDNA.
Measurement of PBGD activity in tissue homogenatesware on an Apple Macintosh personal computer. The
expected lengths for PCR products were 109 bp for After perfusing the left kidney and the liver with “incu-
cDNA and 151 bp for genomic DNA. The amounts of bation solution,” small pieces of tissue were obtained from
cDNA products and those of genomic DNA were as- the liver and the kidney cortex, outer medulla, and in-
sessed from the intensities of the bands, and after correc- ner medulla. The samples were homogenized in 0.25 mol/L
tion for the length of each product, the quantity of sucrose solution. After centrifugation at 105,000 	 g, the
mRNA per cell was expressed as a ratio of these two supernatants were collected. Then, 0.70 mL of superna-
products (CG ratio). tant and 0.2 mL of PBG (0.6 mmol/L) in a Na-phosphate
buffer (0.38 mol/L, pH 7.8) were mixed and incubated
MRT-PCR of -actin in dark at 37C for 60 minutes. After incubation, 0.1 mL
MRT-PCR of another housekeeping gene, -actin, of 0.5 mol/L trichloroacetic acid (TCA) containing 0.6%
also was performed. Since -actin is an abundant tran- iodine was added to terminate the reaction. Then the
script, precise estimation of the amount of its mRNA is samples were centrifuged at 3,000 	 g for five minutes,
difficult using a simple comparison with genomic DNA. and the supernatants collected and used for fluorometric
Thus, another approach was adopted—selective ampli- determination of synthesized uroporphyrin I (URO) us-
fication of genomic DNA (SAG) by several cycles of ing an F-2000 fluorescence spectrophotometer (Hitachi).
PCR—to circumvent this problem. After RT, SAC for The excitation and emission wavelengths were 405 nm
the synthesis of second-strand cDNA and UDG treat- and 597 nm, respectively [8]. The enzyme activity was
ment, samples were placed in several tubes and different expressed as URO (pmol)/tissue amount (mg)/time (h).
cycles of PCR were performed. The primers used here
(SAG primers) were designed to amplify only genomic
RESULTSDNA; sense primer was on a neighboring intron, and
Quantitative analysis of PBGD mRNA in differentantisense primer was downstream on the RT primer.
nephron segments was performed using MRT-PCR. TheAfter SAG, parallel PCR of cDNA and genomic DNA
segments examined were the glomerulus (GL), proximalwere performed using PCR primers common to both
convoluted tubule (PCT), proximal straight tubule (PST),types of DNA. The ratios of cDNA and genomic DNA
medullary thick ascending limb of Henle (mTAL), corti-products (CG ratios) were plotted for the number of
cal thick ascending limb of Henle (cTAL), distal convo-SAG cycles, and the ratio at 0 SAG cycles was calculated
luted tubule (DCT), cortical collecting duct (CCD), andfrom the regression line. The amount of mRNA was
outer medullary collecting duct (OMCD). Figure 1 de-expressed as a CG ratio at 0 SAG cycles.
picts the MRT-PCR results for four different nephron
MRT-PCR for tissue homogenates segments. The results demonstrate that substantially
more PBGD mRNA was expressed in tubular segmentsMRT-PCR of a greater amount of tissues required
than in glomeruli. The experiments were repeated fivehomogenization and purification of nucleic acids. Ho-
times for each segment, each time with samples frommogenization of tissue was performed in “denaturing
different animals. The quantity of PBGD mRNA persolution” and nucleic acids were purified by several steps
cell was expressed as CG ratio. PBGD mRNA levels inof phenol-chloroform extraction. To minimize the loss
different nephron segments were summarized in Table 2.of nucleic acids in these steps, as small an amount of
Since the primers used for MRT-PCR of PBGD weretissue as possible (around the order of 106 L) was used
for these procedures. common to both the erythroid and housekeeping types,
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Fig. 2. Results of MRT-PCR for PBGD and
-actin. (A) The electrophoretic result of
MRT-PCR products for PBGD and -actin
in glomeruli, and (C ) that in PCT are shown.
In each panel, two left-sided lanes are for
PBGD, and other 8 lanes are for -actin. For
-actin, zero to 6 cycles of selective amplifica-
tion of genomic DNA (SAG) are shown on
the right-sided lanes. (B and D) Logarithmic
values of CG ratios plotted for the SAG cycle
numbers.
the presence of the former type of PBGD in nephron
segments cannot be ignored. Conventional RT-PCR us-
ing specific primers on different exons confirmed that
only the housekeeping type was present in these cells
(data not shown).
The difference in PBGD mRNA levels in glomeruli
and tubular segments was confirmed by parallel MRT-
PCR of PBGD and -actin, which is another housekeep-
ing gene. The result of MRT-PCR for PBGD and -actin
in glomeruli and PCT is depicted in Figure 2. Because
-actin cDNA PCR products were abundant compared
to those of genomic DNA, its band was weak compared
with that of cDNA, and it was hardly possible to calculate
the CG ratios from the band densities. To circumvent
this problem, only genomic DNA was amplified (SAG)
prior to parallel PCR of cDNA and genomic DNA. At
Fig. 3. PBGD enzyme activity and mRNA quantities in the kidney0 and 1 SAG cycles, the bands of genomic DNA were
and the liver. PBGD enzyme activity in the kidney inner medulla (IM),
faint. CG ratios for 2 to 6 cycles of SAG demonstrated outer medulla (OM), cortex, and the liver homogenates are plotted for
PBGD mRNA quantities measured by MRT-PCR. The two parametersan exponential decline with an increase in the number
show excellent correlation.of cycles. The calculated CG ratio of -actin at 0 cycles
of SAG in this experiment was 17.8 for glomeruli and
23.8 for PCT, and that of PBGD was 0.79 for glomeruli
and 5.18 for PCT. PCR. The PBGD mRNA levels were 0.88  0.08 in the
Enzyme activity of PBGD in tissue homogenates was inner medulla, 2.08  0.29 in the outer medulla, 2.36 
measured and the results were compared with mRNA 0.33 in the cortex of the kidneys, and 3.17  0.36 in the
levels determined by MRT-PCR. Experiments were per- liver. As shown in Figure 3, the enzyme activity and
formed for the kidney inner medulla, outer medulla, cor- mRNA level of PBGD show excellent correlation.
tex, and the liver. PBGD enzyme activities were (URO
pmol/mg/h) 5.54  0.89 in the inner medulla, 13.26 
DISCUSSION0.95 in the outer medulla, 14.33  0.60 in the cortex of
the kidneys, and 17.57 2.34 in the liver. PBGD mRNA Our study presents a modified method of quantitative
RT-PCR. The difficulty of quantifying mRNA usingin tissue homogenates was also measured using MRT-
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RT-PCR arises from two characteristics of PCR: ampli- with “laser-assisted cell picking” [2], for example, may
present a powerful tool for analyzing mRNA expressionsfication of small variations in each cycle and a plateau
effect at the later cycles. Although introduction of inter- at cell levels.
With all these advantages, using genomic DNA as anal competitive control (“competitive PCR”) solved such
problems and was a great success [9], procedures to pre- standard also may pose some problems. Conventionally,
some kind of RNA such as total RNA, poly-A RNA,pare an artificial competitor are labor-intensive. In con-
trast, the recently introduced real-time quantitative RT- 28s rRNA, or mRNA of a housekeeping gene is used as
the standard. Compared with these methods, estimatingPCR is easy to perform [2]. However, this procedure
requires a specialized facility. In addition, some internal specific mRNA levels per cell by using genomic DNA
as a standard may give higher values in larger cells com-control is necessary and PBGD mRNA has been used
for that purpose [1]. Using a so-called housekeeping pared with smaller cells. In this context, we investigated
the possibility that our result demonstrating a lowergene as a control always presents a problem in that its
expression is not necessarily consistent, as is the case for PBGD mRNA in glomeruli than in tubular segments
may simply reflect the difference in cell sizes. This wasPBGD shown in the present study.
The method used in our research has made several achieved by measuring -actin mRNA in these cells us-
ing the same method as used in PBGD, and similar levelsimprovements compared with the previously reported
MRT-PCR [3]. First, the step of restriction enzyme treat- of -actin mRNA in glomeruli and PCT indicate that
the difference in PBGD mRNA quantity really reflectsment is omitted as it uses deletion mutation instead of
point mutation, thus minimizing the problem of hetero- the difference in its expression. The result that mRNA
per cell and enzyme activity per tissue weight in kidneyduplex [10]. Although an appropriate length of intron
can be exploited for distinguishing the products of cDNA and liver correlated well indicates that the genomic DNA
content per tissue weight in these two organs are similar,and genomic DNA, such an intron may be difficult to
find in many cases. Second, the system of UDG has been which is the case in a reported by David and Frank [11].
In addition to the problem of cell size, yield of RNA andintroduced to remove remaining RT primers. Third,
comparing the amount of cDNA products with those of DNA while preparing samples may vary depending on
cell types. Considering these possible shortcomings, wegenomic DNA is possible only when the amounts of both
of them are comparable, and abundant or rare transcripts must be careful when applying the MRT-PCR in compar-
ing mRNA levels in different cell types. In contrast,were difficult to quantify using the method. The present
study introduced SAG for abundant transcripts. We am- MRT-PCR will be especially suitable for the study of
gene expression in one cell type under different physio-plified genomic DNA up to the point where cDNA and
genomic DNA were about the same amount, and esti- logical conditions where there is no alteration in cell size.
Using the method, we examined PBGD mRNA quan-mated mRNA levels by CG ratios before this point.
Considering the problem of heteroduplex [10], however, tities in microdissected nephron segments. PBGD is the
third enzyme of the heme biosynthetic pathway [12].it may be better to choose the series of cycles where CG
ratios span the value of 1. The same principle as SAG It has two isoforms transcribed from a single gene by
alternative splicing [13]. One of the two is expressed ex-can be applied for rare transcripts by amplifying only
cDNA prior to parallel PCR by repeating SAC treatment clusively in erythroid cells (the erythroid type), whereas
the other is known to be present in all cell types (the(data not shown).
While the concept of an internal control of “competi- housekeeping type). The housekeeping type of PBGD
mRNA has been used as a standard for RT-PCR intive PCR” is successful, the MRT-PCR has three advan-
tages over its predecessor technology, especially when recent studies [2, 14] because its gene is reported to
be free of pseudogenes [1]. PBGD mRNA generally ishandling minute tissue samples. First, the step of prepar-
ing control nucleic acid is not necessary. Second, quanti- believed to be expressed uniformly in all types of tissue
[1]. However, considering that PBGD enzyme activityfying the amount of starting material is not required
because using intrinsic genomic DNA as a standard en- shows tissue dependent variation, even the housekeeping
type of PBGD may represent some tissue specific differ-ables a direct estimation of the levels of mRNA per cell.
Third, no mRNA purification is needed with this method. ences. We have shown that tubular PBGD mRNA was
much more abundant than that in glomeruli. Our resultsFor microdissected nephron segments contamination of
protein was negligible, and both RNA and DNA were suggest that tubular segments express substantially more
PBGD than glomeruli. Such abundant expression ofdirectly precipitated after denaturing cells. In the case
of tissue homogenates, any contaminating protein must PBGD in tubular segments may reflect the fact that heme
proteins such as cytochrome p-450 play important rolesbe removed by an additional step of phenol/chloroform
extraction. This step may result in some loss of nucleic in these cells [15, 16].
The PBGD gene is known to be the target gene foracids. For that reason, using as small an amount of tissue
as possible is recommended. Combining this method the pathogenesis of acute intermittent porphyria (AIP)
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deaminase gene: Structural organization, sequence, and transcrip-[17, 18]. AIP is a form of porphyria, a family of diseases
tional analysis. J Biol Chem 264:14829–14834, 1989
resulting from abnormal activity of one or more of the 7. Frohman MA, Martin GR: Rapid amplification of cDNA ends
using nested primers. Technique 1:165–170, 1989enzymes involved in heme biosynthesis. The organ re-
8. Kondo M, Mori M, Aoki Y: Increased porphobilinogen deaminasesponsible for acute attacks in AIP is generally believed
activity and protoporphyrin content in erythrocytes of patients
to be the liver. However, some studies have indicated that with primary acquired sideroblastic anemia. Acta Haematol Jpn
53:851–859, 1990the kidney also plays an important role in porphyrin me-
9. Gilliland G, Perrin S, Blanchard K, Bunn HF: Analysis oftabolism and thus the pathogenesis of porphyries [19–23].
cytokine mRNA and DNA: Detection and quantification by com-
Histopathological study on renal lesions of patients with petitive polymerase reaction. Proc Natl Acad Sci USA 87:2725–
2729, 1990AIP showed interstitial changes as well as glomeruloscle-
10. Henley WN, Schebel KE, Neilsen DA: Limitations imposed byrosis and ischemic lesions [24]. In addition, severe tubulo-
heteroduplex formation on quantitative RT-PCR. Biochem Bio-
interstitial nephritis complicating AIP was also reported phys Res Commun 226:113–117, 1996
11. David FG, Frank JK: Protein turnover and growth in the whole[25]. The present finding that PBGD mRNA is abundant
body, liver and kidney of the rat from the foetus to senility. Biochemin renal tubular segments may provide another clue to elu-
J 217:507–516, 1984
cidate the role of the kidney in the pathogenesis of AIP. 12. Ponka P: Tissue-specific regulation of iron metabolism and heme
synthesis: Distinct control mechanisms in erythroid cells. BloodIn summary, this study examines a modified method
89:1–25, 1997of quantitative RT-PCR that is simple and reliable. By
13. Chretien S, Dubart A, Beaupain D, et al: Alternative transcrip-
this method we found that the housekeeping type of tion and splicing of the human porphobilinogen deaminase gene
result in tissue-specific or in housekeeping expression. Proc NatlPBGD mRNA expression is under the control of tissue
Acad Sci USA 85:6–10, 1988specific regulation and is expressed in profusion in renal
14. Nagel S, Schmidt M, Thiede C, et al: Quantification of Bcr-Abl
tubular segments. Clarifying the physiological signifi- transcripts in chronic myelogenous leukemia (CML) using standard-
ized, internally controlled, competitive differential PCR (CD-PCR).cance of this plentiful expression of PBGD mRNA in
Nucleic Acids Res 24:4102–4103, 1996these cells will be examined through further research.
15. Bonventre JV, Nemenoff R: Renal tubular arachidonic acid me-
tabolism. Kidney Int 39:438–449, 1991
16. Woods JS: Regulation of porphyrin and heme metabolism in theACKNOWLEDGMENT
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